BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19223002)

  • 1. Oxaliplatin enhances TRAIL-induced apoptosis in gastric cancer cells by CBL-regulated death receptor redistribution in lipid rafts.
    Xu L; Qu X; Zhang Y; Hu X; Yang X; Hou K; Teng Y; Zhang J; Sada K; Liu Y
    FEBS Lett; 2009 Mar; 583(5):943-8. PubMed ID: 19223002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epirubicin enhances TRAIL-induced apoptosis in gastric cancer cells by promoting death receptor clustering in lipid rafts.
    Xu L; Qu X; Luo Y; Zhang Y; Liu J; Qu J; Zhang L; Liu Y
    Mol Med Rep; 2011; 4(3):407-11. PubMed ID: 21468584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cisplatin enhances TRAIL-induced apoptosis in gastric cancer cells through clustering death receptor 4 into lipid rafts].
    Xu L; Qu XJ; Liu YP; Liu J; Zhang Y; Hou KZ; Jiang YH
    Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):484-8. PubMed ID: 22093622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRAIL-activated EGFR by Cbl-b-regulated EGFR redistribution in lipid rafts antagonises TRAIL-induced apoptosis in gastric cancer cells.
    Xu L; Zhang Y; Liu J; Qu J; Hu X; Zhang F; Zheng H; Qu X; Liu Y
    Eur J Cancer; 2012 Nov; 48(17):3288-99. PubMed ID: 22456178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cetuximab enhances TRAIL-induced gastric cancer cell apoptosis by promoting DISC formation in lipid rafts.
    Xu L; Hu X; Qu X; Hou K; Zheng H; Liu Y
    Biochem Biophys Res Commun; 2013 Sep; 439(2):285-90. PubMed ID: 23973713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid raft-regulated IGF-1R activation antagonizes TRAIL-induced apoptosis in gastric cancer cells.
    Xu L; Qu X; Hu X; Zhu Z; Li C; Li E; Ma Y; Song N; Liu Y
    FEBS Lett; 2013 Nov; 587(23):3815-23. PubMed ID: 24161672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-α sensitizes human gastric cancer cells to TRAIL-induced apoptosis via activation of the c-CBL-dependent MAPK/ERK pathway.
    Qu J; Zhao M; Teng Y; Zhang Y; Hou K; Jiang Y; Yang X; Shang H; Qu X; Liu Y
    Cancer Biol Ther; 2011 Sep; 12(6):494-502. PubMed ID: 21725207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of Cbl-b by bufalin results in up-regulation of DR4/DR5 and sensitization of TRAIL-induced apoptosis in breast cancer cells.
    Yan S; Qu X; Xu C; Zhu Z; Zhang L; Xu L; Song N; Teng Y; Liu Y
    J Cancer Res Clin Oncol; 2012 Aug; 138(8):1279-89. PubMed ID: 22447040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-elemene increases the sensitivity of gastric cancer cells to TRAIL by promoting the formation of DISC in lipid rafts.
    Xu L; Guo T; Qu X; Hu X; Zhang Y; Che X; Song H; Gong J; Ma R; Li C; Fan Y; Ma Y; Hou K; Wu P; Dong H; Liu Y
    Cell Biol Int; 2018 Sep; 42(10):1377-1385. PubMed ID: 29957841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bufalin enhances TRAIL-induced apoptosis by redistributing death receptors in lipid rafts in breast cancer cells.
    Yan S; Qu X; Xu L; Che X; Ma Y; Zhang L; Teng Y; Zou H; Liu Y
    Anticancer Drugs; 2014 Jul; 25(6):683-9. PubMed ID: 24710190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells.
    Delmas D; Rébé C; Micheau O; Athias A; Gambert P; Grazide S; Laurent G; Latruffe N; Solary E
    Oncogene; 2004 Nov; 23(55):8979-86. PubMed ID: 15480430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of death receptor translocation into lipid rafts in acquired TRAIL-resistant NSCLC cells.
    Ouyang W; Yang C; Zhang S; Liu Y; Yang B; Zhang J; Zhou F; Zhou Y; Xie C
    Int J Oncol; 2013 Feb; 42(2):699-711. PubMed ID: 23258590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DR5-Cbl-b/c-Cbl-TRAF2 complex inhibits TRAIL-induced apoptosis by promoting TRAF2-mediated polyubiquitination of caspase-8 in gastric cancer cells.
    Xu L; Zhang Y; Qu X; Che X; Guo T; Li C; Ma R; Fan Y; Ma Y; Hou K; Li D; Hu X; Liu B; Yu R; Yan H; Gong J; Liu Y
    Mol Oncol; 2017 Dec; 11(12):1733-1751. PubMed ID: 28972304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apple procyanidins activate apoptotic signaling pathway in human colon adenocarcinoma cells by a lipid-raft independent mechanism.
    Maldonado-Celis ME; Bousserouel S; Gossé F; Lobstein A; Raul F
    Biochem Biophys Res Commun; 2009 Oct; 388(2):372-6. PubMed ID: 19666002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts.
    Psahoulia FH; Drosopoulos KG; Doubravska L; Andera L; Pintzas A
    Mol Cancer Ther; 2007 Sep; 6(9):2591-9. PubMed ID: 17876056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redistribution of DR4 and DR5 in lipid rafts accounts for the sensitivity to TRAIL in NSCLC cells.
    Ouyang W; Yang C; Liu Y; Xiong J; Zhang J; Zhong Y; Zhang G; Zhou F; Zhou Y; Xie C
    Int J Oncol; 2011 Dec; 39(6):1577-86. PubMed ID: 21769428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanism.
    Ortiz-Ferrón G; Yerbes R; Eramo A; López-Pérez AI; De Maria R; López-Rivas A
    Cell Res; 2008 Jun; 18(6):664-76. PubMed ID: 18458681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temozolomide sensitizes stem-like cells of glioma spheres to TRAIL-induced apoptosis via upregulation of casitas B-lineage lymphoma (c-Cbl) protein.
    Zhitao J; Long L; Jia L; Yunchao B; Anhua W
    Tumour Biol; 2015 Dec; 36(12):9621-30. PubMed ID: 26142735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Src/caveolin-1-regulated EGFR activation antagonizes TRAIL-induced apoptosis in gastric cancer cells.
    Xu L; Qu X; Li H; Li C; Liu J; Zheng H; Liu Y
    Oncol Rep; 2014 Jul; 32(1):318-24. PubMed ID: 24840271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Cbl shRNA-expressing adenovirus sensitizes TRAIL-induced apoptosis in prostate cancer DU-145 through increases of DR4/5.
    Kim SY; Kim JH; Song JJ
    Cancer Gene Ther; 2013 Feb; 20(2):82-7. PubMed ID: 23306613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.